Texas Instruments Work in process decreased by 3.6% to $2.37B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $2.21B to $2.37B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 19.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $996.00M | $1.03B | $1.07B | $1.15B | $1.26B | $1.35B | $1.55B | $1.85B | $2.11B | $2.15B | $2.11B | $2.13B | $2.07B | $2.08B | $2.21B | $2.37B | $2.43B | $2.46B | $2.37B |
| QoQ Change | — | +3.8% | +3.2% | +7.9% | +9.3% | +7.1% | +14.8% | +19.7% | +14.1% | +1.8% | -1.8% | +0.9% | -2.7% | +0.4% | +6.4% | +7.0% | +2.5% | +1.3% | -3.6% |
| YoY Change | — | — | — | — | +26.3% | +30.3% | +44.9% | +60.7% | +67.7% | +59.4% | +36.4% | +15.1% | -1.8% | -3.1% | +5.0% | +11.3% | +17.2% | +18.2% | +7.1% |
| % of Inventories | 53.7% | 55.5% | 55.9% | 55.9% | 57.2% | 56.0% | 56.1% | 56.3% | 56.6% | 54.9% | 52.7% | 52.1% | 50.5% | 48.4% | 48.9% | 50.6% | 50.5% | 50.9% | 49.4% |
| Share Change | — | +1.8pp | +0.4pp | +0.0pp | +1.3pp | -1.2pp | +0.0pp | +0.2pp | +0.3pp | -1.6pp | -2.2pp | -0.6pp | -1.7pp | -2.0pp | +0.5pp | +1.7pp | -0.1pp | +0.5pp | -1.6pp |
We use cookies for analytics. See our Privacy and Cookie Policy.